Heterogeneity is a critical but unavoidable aspect of meta-analyses that reflects differences in study outcomes beyond what is expected by chance. These variations arise from differences in the study populations, interventions, methodologies, and measurement tools and can influence key meta-analytical outputs, including pooled effect sizes, confidence intervals, and overall conclusions. Systematic reviews and meta-analyses combine evidence from diverse studies; thus, a clear understanding of heterogeneity is necessary for reliable and meaningful interpretations of the results. This review examines the concepts, sources, measurement techniques, and implications of this heterogeneity. Statistical tools (e.g., Cochran’s Q, I2, and τ2) quantify heterogeneity, whereas τ and prediction intervals, as they use the same units, aid in the intuitive understanding of heterogeneity. The choice between fixed- and random-effects models can also significantly affect the handling and interpretation of heterogeneity in meta-analyses. Effective management strategies include subgroup analyses, sensitivity analyses, and meta-regressions, which identify sources of variability and strengthen the robustness of the findings. Although heterogeneity complicates the synthesis of a single effect size, it offers valuable insights into patterns and differences among studies. Recognizing and understanding heterogeneity is vital for accurately synthesizing the evidence, which can indicate whether an intervention has consistent effects, benefits, or harms. Rather than viewing heterogeneity as inherently good or bad, researchers and clinicians should consider it a key component of systematic reviews and meta-analyses, allowing for a deeper understanding and more nuanced application of pooled findings. Addressing heterogeneity ultimately enhances the reliability, applicability, and overall impact of the conclusions of meta-analyses.

Choi GJ, et al. J Lipid Atheroscler. 2023 Jan;12(1):3-11. https://doi.org/10.12997/jla.2023.12.1.3

Geun Joo Choi and Hyun Kang. Korean J Pain 2022;35:127-8. https://doi.org/10.3344/kjp.2022.35.2.127

Choi GJ, et al. J Lipid Atheroscler. 2020 Sep;9(3):435-448. https://doi.org/10.12997/jla.2020.9.3.435

Kang H, et al. J Korean Med Sci. 2014 Dec;29(12):1610-1617. http://dx.doi.org/10.3346/jkms.2014.29.12.1610

Ginseng saponin has long been used as a traditional Asian medicine and is known to be effective in treating various kinds of pain. Ginsenoside Rf is one of the biologically active saponins found in ginseng. We evaluated ginsenoside Rf's antinociceptive and anti-inflammatory effects, and its mechanism of action on adrenergic and serotonergic receptors, in an incisional pain model. Mechanical hyperalgesia was induced via plantar incision in rats followed by intraperitoneal administration of increasing doses of ginsenoside Rf (vehicle, 0.5 mg/kg, 1 mg/kg, 1.5 mg/kg, and 2 mg/kg). The antinociceptive effect was also compared in a Positive Control Group that received a ketorolac (30 mg/kg) injection, and the Naïve Group, which did not undergo incision. To evaluate the mechanism of action, rats were treated with prazosin (1 mg/kg), yohimbine (2 mg/kg), or ketanserin (1 mg/kg) prior to receiving ginsenoside Rf (1.5 mg/kg). The mechanical withdrawal threshold was measured using von Frey filaments at various time points before and after ginsenoside Rf administration. To evaluate the anti-inflammatory effect, serum interleukin (IL)-1β, IL-6, and tumor necrotizing factor-α levels were measured. Ginsenoside Rf increased the mechanical withdrawal threshold significantly, with a curvilinear dose-response curve peaking at 1.5 mg/kg. IL-1β, IL-6, and tumor necrotizing factor-α levels significantly decreased after ginsenoside Rf treatment. Ginsenoside Rf's antinociceptive effect was reduced by yohimbine, but potentiated by prazosin and ketanserin. Intraperitoneal ginsenoside Rf has an antinociceptive effect peaking at a dose of 1.5 mg/kg. Anti-inflammatory effects were also detected.